Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab for Charcot foot in diabetes mellitus
ACTRN12614000326695Phase 2Recruiting
- Sponsor
- South Western Sydney Local Health District
- Start
- Sep 2014
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of denosumab in Charcot neuroarthropathy (CN), sponsored by South Western Sydney Local Health District. Primary endpoint: Time to foot temperature normalization. Started Sep 2014; status: recruiting.
02
Drugs
denosumab
03
Conditions
Charcot neuroarthropathy (CN)
Beyond the preview
Go deeper on ACTRN12614000326695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000326695.